hemangiol
pierre fabre medicament - propranolol hydroklorid - hemangiom - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
pranolol 20 mg
actavis group ptc ehf (1) - propranololhydroklorid - tablett - 20 mg
pranolol 40 mg
actavis group ptc ehf (1) - propranololhydroklorid - tablett - 40 mg
pranolol 80 mg
actavis group ptc ehf (1) - propranololhydroklorid - tablett - 80 mg
propranolol accord 10 mg
accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 10 mg
propranolol accord 40 mg
accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 40 mg
propranolol accord 80 mg
accord healthcare b.v. - propranololhydroklorid - tablett, filmdrasjert - 80 mg